成長する腫瘍に対する自発的な新抗原特異性CD4+T細胞反応は,機能的にも現象的にも多様である
Ryan Q Griswold1,2, Spencer E Brightman1,2, Karla Soria Zavala2
1University of California San Diego, La Jolla, California, USA.
Journal for immunotherapy of cancer
|September 4, 2025
まとめ
この研究は,がんにおけるCD4+T細胞を調査し,腫瘍に対する様々な免疫反応を明らかにした. 治療的ワクチン接種はこれらの反応を再構成し 調節性T細胞を強調します
科学分野:
- 免疫学
- 癌 研究
- T細胞生物学
背景:
- CD4+ T細胞は,多様な機能的なサブセットを通じて細胞免疫を調節するために不可欠です.
- 腫瘍の成長は,新抗原特異性CD4+T細胞の反応を抑制することによって,免疫制御を回避することができます.
- 腫瘍に対するCD4+T細胞のレパートリーの開発と特性はよく理解されていません.
研究 の 目的:
- 成長する腫瘍に対するCD4+T細胞の反応のオントジェニーと多様性を特徴付ける.
- これらのT細胞反応に対する治療ペプチドワクチンの影響を調査する.
- アドプティブ・セル・セラピー (ACT) の T 調節細胞 (Tregs) の可能性を調査する.
主な方法:
- CD4+ T細胞を追跡するために,特定のネオアンチゲン (CTLCH129>Q/I-Ak) のテトラマーを使用した.
- フローサイトメトリ,単細胞ゲノミクス,T細胞受容体 (TCR) 遺伝子工学を使用した.
- 腫瘍の成長とワクチン接種後の主要な組織適合性複合体II欠陥腫瘍モデル (SCC VII) での反応を研究した.
主要な成果:
- 腫瘍に対する天然のCD4+T細胞の反応は多様で,Tヘルパー1,T卵泡ヘルパー様,Tレグサブセットを含む.
- 治療的ワクチン接種は特定のTレグの頻度を下げ,T細胞のレパートリーを変えた.
- 単細胞分析では,機能的なサブセット内の多様なTCRの親和性が示され,低親和性Treg由来TCRはACTで治療効果を示した.
結論:
- 新抗原特異性CD4+T細胞の機能的多様性および免疫療法の効果に関する新しい洞察を提供します.
- がんワクチンの免疫モニタリングと チェックポイントブロック治療の改善の可能性を示唆している.
- Tregsは養子細胞療法のための強力なTCRの源となる可能性があることを示しています.
さらに関連する動画
関連する概念動画
T Cell Activation and Clonal Selection
4.4K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
4.4K
Tumor Immunotherapy
658
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
658
Cytotoxic T Cells-mediated Immune Response
1.9K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
1.9K
Cancer Stem Cells and Tumor Maintenance
5.0K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.0K
Tumor Progression
6.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K
Special Features of Adaptive Immunity
1.1K
The adaptive immune system, a crucial component of the overall immune response, offers a highly specialized defense against pathogens. It involves specific cell types and features, enabling it to combat infections effectively and efficiently.
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...
1.1K


